Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04007419 · ClinicalTrials.gov registry record · NA
Health Promoters and Organ Donation
A NA study of Organ Donation and Donor Designation/Registration, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 621
- Enrollment target
- 1
- Study location
NCT04007419: Completed NA study of Organ Donation and Donor Designation/Registration, sponsored by Temple University.
NCT04007419 is a NA study of Organ Donation and Donor Designation/Registration that has completed, run by Temple University. The registered enrollment target is 621 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04007419, a NA study of Organ Donation and Donor Designation/Registration, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 621 participants
- Enrollment target
- 1
- Study location
Study Summary
Older Hispanics (age 50+ years) are disproportionately overrepresented on the transplant waitlist, but underrepresented as deceased donors and transplant recipients. This application proposes the formative research to design and empirically test an eLearning module, Promotoras de Donación, to train community health workers (i.e., Promotoras), who already provide culturally and linguistically sensitive services to their communities, to discuss and promote organ donation with older Hispanic women in 3 geographically distinct communities across the U.S. The proposed intervention leverages the established and evidence-based Promotoras program to increase rates of donor designation within Hispanic communities across the U.S. and reduce disparities in access to transplantation for this population.
Primary Outcome
The proportion of mature Latina attending the trained lay health educator-led small group sessions who also register their intent to become a posthumous organ, tissue and eye donor
Conditions Studied
Interventions
- BEHAVIORAL Health Promoters and Organ Donation
Study Locations (1)
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2020-04-27 |
| Phase | NA |
What the finished NCT04007419 record still lists
NCT04007419 is an interventional study that assigns participants to a tested intervention. The registered 621 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Organ Donation appearing as the primary indexed condition, and to 1 intervention - of which Health Promoters and Organ Donation is the first listed.
NCT04007419 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04007419 about?
NCT04007419 is a clinical study titled "Health Promoters and Organ Donation". Older Hispanics (age 50+ years) are disproportionately overrepresented on the transplant waitlist, but underrepresented as deceased donors and transplant recipients. This application proposes the formative research to design and empirically test an eLearning module, Promotoras de Donación, to train ...
What is the current status of trial NCT04007419?
This trial is currently completed. It is a NA study. The enrollment target is 621 participants. The study started on 2016-09-01. Estimated completion is 2020-04-27.
What conditions does trial NCT04007419 study?
This clinical trial studies the following conditions: Organ Donation, Donor Designation/Registration.
What interventions are being tested in trial NCT04007419?
The interventions under investigation include: Health Promoters and Organ Donation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04007419?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04007419 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Organ Donation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04007419's enrollment target sits among peer trials
621 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712355 · 621 participants · Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- NCT05538910 · 620 participants · NA
Defining Neurobiological Links Between Substance Use and Mental Illness
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI